About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The Liver Diseases group is a referent at the local, national and international level in research, and is one of the most active groups in clinical research at VHIR. The group's prominent involvement in clinical trials is a clear indication of our professionals' commitment to ensuring that patients have access to state-of-the-art therapies. Our participation and collaboration in international projects and consortiums are also a fundamental characteristic of the group. The main objective of the group is to become one of the best translational research groups in liver diseases. It is essential to be able to apply all the findings of basic research to clinical research to improve the health of patients with liver disease.
PMID: 33632708 Journal: GUT Year: 2022 Reference: Gut. 2022 Feb;71(2):415-423. doi: 10.1136/gutjnl-2020-323729. Epub 2021 Feb 25. Impact factor: Publication type: Paper in international publication Authors: Abreu, Nelia; Benini, Federica; Burbaum, Barbara; Chorostowska-Wynimko, Joanna; Clark, Virginia; Ellis, Paul; Fromme, Malin; Gaisa, Nadine T; Gaspar, Rui; Genesca, Joan et al. DOI: 10.1136/gutjnl-2020-323729
PMID: 34764217 Journal: JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH Year: 2022 Reference: J Epidemiol Community Health. 2022 Feb;76(2):105-106. doi: 10.1136/jech-2021-217988. Epub 2021 Nov 11. Impact factor: Publication type: Letter or abstract Authors: Benach, Joan; Cash-Gibson, Lucinda; Martinez-Herrera, Eliana; Pericas, Juan M; Zografos, Christos et al. DOI: 10.1136/jech-2021-217988
PMID: 34992134 Journal: GUT Year: 2022 Reference: Gut. 2022 Sep;71(9):1856-1866. doi: 10.1136/gutjnl-2021-324295. Epub 2022 Jan 6. Impact factor: Publication type: Paper in international publication Authors: Abraldes, Juan G; Alboraie, Mohamed; Altamirano, Jose; Alvarado, Edilmar; Alves, Antonio; Argemi, Josepmaria; Barace, Sergio; Bataller, Ramon; Bosques, Francisco; Brown, Robert et al. DOI: 10.1136/gutjnl-2021-324295
PMID: 34989164 Journal: Hepatology Communications Year: 2022 Reference: Hepatol Commun. 2022 Jun;6(6):1392-1402. doi: 10.1002/hep4.1889. Epub 2022 Jan 6. Impact factor: Publication type: Paper in international publication Authors: Albillos, Agustin; Diaz-Fontenla, Fernando; Fernandez-Rodriguez, Conrado; G-Abraldes, Juan; Garcia-Eliz, Maria; Garcia-Retortillo, Montserrat; Gomez-Camarero, Judith; Gomez-Outomuro, Ana; Gratacos-Gines, Jordi; Guerrero, Marta et al. DOI: 10.1002/hep4.1889
PMID: 34943471 Journal: Diagnostics Year: 2021 Reference: Diagnostics (Basel). 2021 Nov 29;11(12). pii: diagnostics11122236. doi: 10.3390/diagnostics11122236. Impact factor: 3.706 Publication type: Paper in international publication Authors: Buti, Maria, Blanco-Grau, Albert, Gabriel-Medina, Pablo, Rodriguez-Algarra, Francisco, Villena, Yolanda, Lopez-Martinez, Rosa, Augustin, Salvador, Pons, Monica, Cruz, Luz-Maria, Rando-Segura, Ariadna et al. DOI: 10.3390/diagnostics11122236
PMID: 34946123 Journal: Microorganisms Year: 2021 Reference: Microorganisms. 2021 Dec 6;9(12). pii: microorganisms9122518. doi: 10.3390/microorganisms9122518. Impact factor: 4.128 Publication type: Review in international publication Authors: Tabernero, David, Rodriguez-Frias, Francisco, Quer, Josep, Rando-Segura, Ariadna, Pumarola, Tomas, Garcia-Garcia, Selene, Cortese, Maria Francesca et al. DOI: 10.3390/microorganisms9122518
PMID: 34887634 Journal: WORLD JOURNAL OF GASTROENTEROLOGY Year: 2021 Reference: World J Gastroenterol. 2021 Nov 7;27(41):7144-7158. doi: 10.3748/wjg.v27.i41.7144. Impact factor: 5.742 Publication type: Paper in international publication Authors: Garcia-Garcia, Selene, Cortese, Maria Francesca, Tabernero, David, Gregori, Josep, Vila, Marta, Pacin, Beatriz, Quer, Josep, Casillas, Rosario, Castillo-Ribelles, Laura, Ferrer-Costa, Roser et al. DOI: 10.3748/wjg.v27.i41.7144
PMID: 34865052 Journal: JOURNAL OF INFECTIOUS DISEASES Year: 2021 Reference: J Infect Dis. 2021 Dec 4. pii: 6449510. doi: 10.1093/infdis/jiab589. Impact factor: 5.226 Publication type: Paper in international publication Authors: Rico, Angie, Piron, Maria, Bes, Marta, Sauleda, Silvia, Costafreda, Maria Isabel et al. DOI: 10.1093/infdis/jiab589
PMID: 32515985 Journal: AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY Year: 2020 Reference: Am J Respir Cell Mol Biol. 2020 Oct;63(4):444-451. doi: 10.1165/rcmb.2020-0021OC. Impact factor: 5.373 Publication type: Paper in international publication Authors: Matamala, Nerea, Gomez-Mariano, Gema, Perez, Jose Antonio, Baladron, Beatriz, Torres-Duran, Maria, Michel, Francisco Javier, Saez, Raquel, Hernandez-Perez, Jose Maria, Belmonte, Irene, Rodriguez-Frias, Francisco et al. DOI: 10.1165/rcmb.2020-0021OC
PMID: 32496109 Journal: REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS Year: 2020 Reference: Rev Esp Enferm Dig. 2020 Sep;112(9):712-715. doi: 10.17235/reed.2020.6600/2019. Impact factor: 1.591 Publication type: Paper in international publication Authors: Armengol Bertroli, Jordi, Pascasio-Hernandez, Mario Jose, Benages Curell, Anna, Castillo Cejas, Maria Dolores, Pigrau Pastor, Marc, Sihuay Diburga, Denisse, Guevara Cubas, Jorge, Castro-Reyes, Luz Maria, Jimenez Hernandez, Cesar, Tasayco Huaman, Stephanie et al. DOI: 10.17235/reed.2020.6600/2019
PMID: 32336663 Journal: Surgery for Obesity and Related Diseases Year: 2020 Reference: Surg Obes Relat Dis. 2020 Sep;16(9):1361-1369. doi: 10.1016/j.soard.2020.03.013. Epub 2020 Mar 20. Impact factor: 3.812 Publication type: Paper in international publication Authors: Talavera-Urquijo, Eider, Beisani, Marc, Balibrea, Jose M, Alverdy, John C et al. DOI: 10.1016/j.soard.2020.03.013
PMID: 32329119 Journal: LIVER INTERNATIONAL Year: 2020 Reference: Liver Int. 2020 Aug;40(8):1906-1916. doi: 10.1111/liv.14489. Epub 2020 Jun 3. Impact factor: 5.175 Publication type: Paper in international publication Authors: Riveiro-Barciela, Mar, Barreira-Diaz, Ana, Vidal-Gonzalez, Judit, Munoz-Couselo, Eva, Martinez-Valle, Fernando, Viladomiu, Lluis, Minguez, Beatriz, Ortiz-Velez, Carolina, Castells, Lluis, Esteban, Rafael et al. DOI: 10.1111/liv.14489
The consensus establishes recommendations that could correct the current disparities related to muscle mass, weight and height and would allow for more precise prioritization of patients who require transplants more urgently.
Using computed tomography (CT), with or without contrast, it is possible to perform an accurate and safe detection of the disease without the need for biopsies and avoiding the limitations of other non-invasive diagnostic tools.
On World Clinical Trials Day, we highlight some of the studies we have participated in that confirm the efficacy of new drugs, allowing their approval by regulatory agencies.
Des de Vall d'Hebron estem buscant 200 persones voluntàries sanes d'entre 18 i 30 anys per a participar en un estudi sobre els patrons de consum habitual de l'alcohol en població jove, en el marc del projecte StopALD.
